These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9472714)

  • 1. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog.
    Johnson AS; Couto CG; Weghorst CM
    Carcinogenesis; 1998 Jan; 19(1):213-7. PubMed ID: 9472714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 gene mutations in osteosarcomas in the dog.
    van Leeuwen IS; Cornelisse CJ; Misdorp W; Goedegebuure SA; Kirpensteijn J; Rutteman GR
    Cancer Lett; 1997 Jan; 111(1-2):173-8. PubMed ID: 9022143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 gene mutations in canine osteosarcoma.
    Kirpensteijn J; Kik M; Teske E; Rutteman GR
    Vet Surg; 2008 Jul; 37(5):454-60. PubMed ID: 18986312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of the p53, Rb and MDM2 genes in canine osteosarcoma.
    Mendoza S; Konishi T; Dernell WS; Withrow SJ; Miller CW
    Anticancer Res; 1998; 18(6A):4449-53. PubMed ID: 9891508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 gene mutations in osteosarcomas of low-grade malignancy.
    Radig K; Schneider-Stock R; Haeckel C; Neumann W; Roessner A
    Hum Pathol; 1998 Nov; 29(11):1310-6. PubMed ID: 9824113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
    Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
    Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors.
    Yokoyama R; Schneider-Stock R; Radig K; Wex T; Roessner A
    Pathol Res Pract; 1998; 194(9):615-21. PubMed ID: 9793960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs.
    Sagartz JE; Bodley WL; Gamblin RM; Couto CG; Tierney LA; Capen CC
    Vet Pathol; 1996 Mar; 33(2):213-21. PubMed ID: 8801715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathologic relevance of p53 index in canine osseous tumors.
    Loukopoulos P; Thornton JR; Robinson WF
    Vet Pathol; 2003 May; 40(3):237-48. PubMed ID: 12724563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.
    Levine RA; Fleischli MA
    Vet Pathol; 2000 Jan; 37(1):54-61. PubMed ID: 10643981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological relevance of tumour grading in canine osteosarcoma.
    Loukopoulos P; Robinson WF
    J Comp Pathol; 2007 Jan; 136(1):65-73. PubMed ID: 17270206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma.
    Gokgoz N; Wunder JS; Mousses S; Eskandarian S; Bell RS; Andrulis IL
    Cancer; 2001 Oct; 92(8):2181-9. PubMed ID: 11596036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
    Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
    J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
    Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
    Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
    Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
    Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors.
    Levine RA; Forest T; Smith C
    Vet Pathol; 2002 May; 39(3):372-8. PubMed ID: 12014501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrations of the p53 tumor suppressor gene in various tumors in dogs.
    Setoguchi A; Sakai T; Okuda M; Minehata K; Yazawa M; Ishizaka T; Watari T; Nishimura R; Sasaki N; Hasegawa A; Tsujimoto H
    Am J Vet Res; 2001 Mar; 62(3):433-9. PubMed ID: 11277210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.